CHCHD2 and Parkinson disease: Within affected brain regions, compared to healthy controls, both the number of CHCHD2 positive neurons and its level of expression in surviving neurons were reduced in the substantia nigra of PD patients (Figs. 2 and 3), suggesting the possibility of an interaction between PD pathological processes (e.g., accumulation of pathological α-synuclein species) and CHCHD2 reduction.